Unani Formulation in the management of Urinary Incontinence

Therapeutic Evaluation of Unani Formulation in Stress Urinary Incontinence (Salisululbol): A Randomized Controlled Study.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/012977

Enrollment

Registered

2018-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- stress Urinary incontinence

Interventions

Intervention1: Unani formulatio: Mur (Commiphora myrrha) Balut (Quercus incana) Saadkofi (Cyperus scariosus) Kundur (Boswalia serrata) in the capsulee form thrice a day for 60 days Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: Patients of SUI clinically assessed will be included in the study after obtaining their voluntary consent

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Women on OCPs Patients with 3rd and 4th degree genital prolapse history of systemic illnesses, endocrinal diseases and malignancies history ofany pharmacological intervention within 3 months and have had surgical intervention for SUI.

Design outcomes

Primary

Measure	Time frame
Reduction in the number of incontinent episode assessed by bladder diary. Reduction in ICIQ-SF score. Timepoint: 60days	—

Secondary

Measure	Time frame
Pelvic floor muscle strength assessed by Modified Oxford Grading Scale. Stress test Timepoint: 60days	—

Countries

India

Contacts

Public ContactDr Mariyam Roqaiya

Luqman Unani Medical College, Hospital and Research Centre

dr.mroqaiya@gmail.com9632560839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026